Abbott | ABT - Ebitda





Ebitda Veränderung Datum
Abbott USD 2.43B 844M 2026-03
Agilent USD 456M 84M 2025-12
AtriCure USD 27.28M 10.21M 2026-06
Baxter International USD 309M 756M 2026-03
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD -636.6M 1.62B 2026-03
Boston Scientific USD 1.63B 27M 2026-06
Cooper Companies USD 323.4M 13.2M 2025-12
Danaher USD 1.84B 81M 2026-06
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Globus Medical USD 231.83M 48.62M 2026-03
Insulet USD 199.8M 18.1M 2026-06
Integra LifeSciences USD 78.41M 2.23M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
J&J USD 8.27B 1.08B 2026-03
Medtronic USD 2.81B 119M 2026-03
Merit Medical Systems USD 104.39M 10.97M 2026-06
Pfizer USD 6.01B 18M 2026-06
Smith & Nephew USD 796M 139M 2025-12
Solventum Corp USD 670M 233M 2026-06
Stryker USD 1.93B 357M 2026-06
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 75.63M 171.44M 2026-03
Terumo JPY 57.88B 12.1B 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06